2023
DOI: 10.32481/djph.2023.04.008
|View full text |Cite
|
Sign up to set email alerts
|

Human Papilloma Virus (HPV) and the Current State of Oropharyngeal Cancer Prevention and Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…Therefore, adopting a vigilant approach to sexual practices becomes a crucial recommendation [ 18 ]. We also need to deal with the new, emerging evidence that in developed countries, OSCC has become the most frequent HPV-related cancer, surpassing cervical cancer [ 19 ]. Furthermore, it is predicted that by 2030, most squamous cell carcinomas will be HPV-related rather than the non-HPV-related form [ 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, adopting a vigilant approach to sexual practices becomes a crucial recommendation [ 18 ]. We also need to deal with the new, emerging evidence that in developed countries, OSCC has become the most frequent HPV-related cancer, surpassing cervical cancer [ 19 ]. Furthermore, it is predicted that by 2030, most squamous cell carcinomas will be HPV-related rather than the non-HPV-related form [ 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…Globally, at least eleven percent of cancer cases are due to virus infection 1–5 . DNA viruses, such as EBV, Human Papillomaviruses (HPV), and HBV, are some of the most commonly associated with cancer and are frequently reported to be integrated into the human genome.…”
Section: Introductionmentioning
confidence: 99%
“…1 Despite the development of successful prophylactic vaccines, the incidence of HPVassociated cancers continues to rise. 2 During HPV infection, the HPV E6 and E7 viral oncoproteins disrupt the activity of cellular tumor suppressor proteins leading to tumorigenesis. 3 The tumor-specific expression of these oncoproteins provides several antigenic targets for immunotherapeutic treatments.…”
mentioning
confidence: 99%
“…Persistent infection with high-risk HPV is the leading cause of several cancers affecting more than 45,000 new patients annually in the US alone . Despite the development of successful prophylactic vaccines, the incidence of HPV-associated cancers continues to rise . During HPV infection, the HPV E6 and E7 viral oncoproteins disrupt the activity of cellular tumor suppressor proteins leading to tumorigenesis .…”
mentioning
confidence: 99%